Evidence for Activity of GBR830 (Anti-Ox40) in Extrinsic and Intrinsic Atopic Dermatitis (AD) in a Phase 2a Study

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.385
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Intrinsic Atopic Dermatitis Shows Similar TH2 and Higher TH17 Immune Activation Compared With Extrinsic Atopic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2013English

Assessment of the Impact of the A-896g Polymorphism of the TLR-4 Gene in Adults With Extrinsic and Intrinsic Atopic Dermatitis

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Atopic Dermatitis: Infantile Phase

Klinicheskaya Dermatologiya i Venerologiya
DermatologyInfectious Diseases
2018English

Low Power Laser (LPL) Therapy for Atopic Dermatitis (AD)

THE JOURNAL OF JAPAN SOCIETY FOR LASER SURGERY AND MEDICINE
1994English

Phase 1 Study of Crisaborole in Japanese Healthy Volunteers and Patients With Atopic Dermatitis

Journal of Dermatology
DermatologyMedicine
2019English

1088 Efficacy of AD-DER Emollient in an in Vitro Atopic Dermatitis Model

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Dupilumab in Atopic Dermatitis: Rationale, Latest Evidence and Place in Therapy

Therapeutic Advances in Chronic Disease
Medicine
2018English

714 Productivity Losses in Adults With Atopic Dermatitis (AD): A Cross-Sectional Study From Clinical Practices in Europe and Canada

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

A Phase 2 Randomized Trial of Apremilast in Patients With Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy